The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832587355588919296 |
---|---|
author | Ines Aguinaga-Ontoso Sara Guillen-Aguinaga Laura Guillen-Aguinaga Rosa Alas-Brun Miriam Guillen-Aguinaga Luc Onambele Enrique Aguinaga-Ontoso Esperanza Rayón-Valpuesta Francisco Guillen-Grima |
author_facet | Ines Aguinaga-Ontoso Sara Guillen-Aguinaga Laura Guillen-Aguinaga Rosa Alas-Brun Miriam Guillen-Aguinaga Luc Onambele Enrique Aguinaga-Ontoso Esperanza Rayón-Valpuesta Francisco Guillen-Grima |
author_sort | Ines Aguinaga-Ontoso |
collection | DOAJ |
description | Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities. |
format | Article |
id | doaj-art-5f1e0070728b4cd6b82de28014063422 |
institution | Kabale University |
issn | 2076-393X |
language | English |
publishDate | 2024-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj-art-5f1e0070728b4cd6b82de280140634222025-01-24T13:51:38ZengMDPI AGVaccines2076-393X2024-12-01131610.3390/vaccines13010006The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)Ines Aguinaga-Ontoso0Sara Guillen-Aguinaga1Laura Guillen-Aguinaga2Rosa Alas-Brun3Miriam Guillen-Aguinaga4Luc Onambele5Enrique Aguinaga-Ontoso6Esperanza Rayón-Valpuesta7Francisco Guillen-Grima8Department of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainDepartment of Nursing, Kystad Helse-og Velferdssenter, 7026 Trondheim, NorwayDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainNeoma Business School, 75013 Paris, FranceSchool of Health Sciences, Catholic University of Central Africa, Yaoundé 1110, CameroonDepartment of Sociosanitary Sciences, University of Murcia, 30003 Murcia, SpainDepartment of Nursing, Complutense University of Madrid, 28040 Madrid, SpainDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainBackground: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.https://www.mdpi.com/2076-393X/13/1/6DTP3 vaccinationCOVID-19 pandemic impactvaccination trendsEurope |
spellingShingle | Ines Aguinaga-Ontoso Sara Guillen-Aguinaga Laura Guillen-Aguinaga Rosa Alas-Brun Miriam Guillen-Aguinaga Luc Onambele Enrique Aguinaga-Ontoso Esperanza Rayón-Valpuesta Francisco Guillen-Grima The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) Vaccines DTP3 vaccination COVID-19 pandemic impact vaccination trends Europe |
title | The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) |
title_full | The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) |
title_fullStr | The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) |
title_full_unstemmed | The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) |
title_short | The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023) |
title_sort | impact of covid 19 on dtp3 vaccination coverage in europe 2012 2023 |
topic | DTP3 vaccination COVID-19 pandemic impact vaccination trends Europe |
url | https://www.mdpi.com/2076-393X/13/1/6 |
work_keys_str_mv | AT inesaguinagaontoso theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT saraguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT lauraguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT rosaalasbrun theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT miriamguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT luconambele theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT enriqueaguinagaontoso theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT esperanzarayonvalpuesta theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT franciscoguillengrima theimpactofcovid19ondtp3vaccinationcoverageineurope20122023 AT inesaguinagaontoso impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT saraguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT lauraguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT rosaalasbrun impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT miriamguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT luconambele impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT enriqueaguinagaontoso impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT esperanzarayonvalpuesta impactofcovid19ondtp3vaccinationcoverageineurope20122023 AT franciscoguillengrima impactofcovid19ondtp3vaccinationcoverageineurope20122023 |